Editorial: Cancer genomics in the era of precision medicine.

The article discusses the role of cancer genomics in the era of precision medicine. It highlights how advancements in sequencing technology and big data analysis have made genomics a key component of cancer research, providing insights into disease etiology, risk assessment, and treatment resistance mechanisms. The article also emphasizes the use of cancer genomics in guiding clinical decisions, such as determining hereditary cancer risk, predicting prognosis, and informing treatment selection. Additionally, it explores the classification of acute myeloid leukemia patients based on genomic features and chromosomal abnormalities, as well as the impact of epigenetic modifications on tumorigenesis. Overall, the article demonstrates how cancer genomics can contribute to a more personalized approach to cancer treatment and care. [Extracted from the article]